Our projects look at the practical side of cancer care — how services are networked across hospitals, how people are followed up after treatment, and how promising new diagnostics are put safely into practice — bringing together clinical, health-economic and health-systems expertise across countries.
Collaborative projects — some running, some completed — spanning how cancer care is organised, delivered and paid for.
An international Lorentz Center workshop bringing together researchers, policymakers, data specialists and people with lived experience to treat screening inequity as a systems challenge — developing equity-sensitive metrics and inclusive design principles to strengthen screening systems.
PRedicting the population health economic IMpact of Current And new CAncer Treatments: data-driven whole-disease simulation models that forecast how many patients will be eligible for new therapies — by cancer stage and treatment line — to inform reimbursement decisions and health-system planning.
PRostatE CancEr Prognosis and Treatment: developing and validating new tests to guide patient and clinician decisions in high-risk prostate cancer — tackling metastasis, therapy resistance and disease progression through an international, data-driven collaboration.
Technology Assessment of Next Generation sequencing in personalized Oncology: early health-technology assessment and dynamic simulation modelling of whole-genome and next-generation sequencing — estimating the impact on time-to-treatment, costs and patient demand to support nationwide implementation.
The AWARD criteria — a practical framework (Agnostic vs. tumour-specific, Workflow, Advancing outcomes, Reimbursable price, Downstream effects) to guide when and how blood-based liquid-biopsy tests move from research into routine cancer management.
Practical themes across how cancer care is organised, delivered and paid for.
Concentration of care and hub-and-spoke networks — how services are configured to improve quality and access.
Tailoring follow-up after primary treatment to individual risk, reducing both over- and under-monitoring.
Moving innovations such as liquid biopsies and genomics from research into routine cancer management.
Fair access to care and the long-term affordability and sustainability of cancer services.
Our work is grounded in health-economics and health-services research, and we partner with academic groups, clinical networks and health-system organisations.
Bring a question from your own system, a dataset, or a project you'd like a health-economics and health-systems partner on.
